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ABSTRACT  
Purpose: A mutation miR-184(+57C>T) in the seed region of miR-184 (encoded by MIR184 
[MIM*613146]) results in familial severe keratoconus combined with early-onset anterior 
polar cataract and endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal 
thinning (EDICT) syndrome (MIM#614303). In order to investigate the phenotypic spectrum 
resulting from MIR184 mutation, MIR184 was sequenced in a keratoconus cohort of mixed 
ethnicity and a Chinese axial myopia cohort. 
Methods: Sequencing of MIR184 was performed in 780 unrelated keratoconus patients and 
96 unrelated Han southern Chinese subjects with axial myopia. Effects of identified 
mutations on RNA secondary structure were predicted computationally using mFold and 
RNAFold algorithms. MIR184 amplicons from patients harbouring mutations were cloned 
and transfected into HEK293T cells and mature mutant miR-184 expression analysed by 
stem-loop RT-qPCR. 
Results: Two novel heterozygous substitution mutations in MIR184 were identified in the 
two patients with isolated keratoconus: miR-184(+8C>A) and miR-184(+3A>G). 
Computational modelling predicted that these mutations alter the miR-184 stem loop stability 
and secondary structure. Ex vivo miR-184 expression analysis demonstrated that miR-
184(+8C>A) almost completely repressed the expression of miR-184 (P = 0.022) and miR-
184(+3A>G) reduced the expression of miR-184 by approximately 40% (P = 0.002). There 
was no significant association of rs41280052, which lies within the stem loop of miR-184, 
with keratoconus. No MIR184 mutations were detected in the axial myopia cohort. 
Conclusions: Two novel heterozygous substitution mutations in MIR184 were identified in 
the two patients with isolated keratoconus: miR-184(+8C>A) and miR-184(+3A>G). 
Mutations in MIR184 are a rare cause of keratoconus and were found in 2/780 (0.25%) cases.   
4 
Introduction 
Keratoconus (MIM#148300), a common disorder of the corneal shape and structure
1
, is the
leading indication for corneal transplantation in the developed world
2
. Clinically, keratoconus
manifests as a bilateral, non-inflammatory progressive corneal ectasia in which the cornea 
protrudes and thins, manifesting as progressive myopia and irregular astigmatism
1, 3
. 
Clinically, the severity of keratoconus ranges from the mild subclinical forme fruste 
keratoconus to myopia and irregular astigmatism to severe progressive conical protrusion, 
scarring, or blindness
1, 3
. Keratoconus is a lifelong condition which is a significant health
burden in work-age adults, affecting quality of life
4
. Despite the visual and social impact of
keratoconus
5, 6
, the underlying biochemical processes and pathobiology remain poorly 
understood
1
.
There is strong evidence that keratoconus has a genetic basis
1, 7-11
, but, to date, few if any
genes have been identified. Mutations in the visual system homeobox gene 1 (VSX1; 
MIM*605020) on 20p11.2 (KTCN1; MIM#148300) have been described in keratoconus
12
.
However, this has proved a controversial finding
13
, and further studies excluded sequence
changes in the VSX1 gene as the cause of disease in their patient populations
14-16
,
demonstrating that VSX1 is not a major cause of keratoconus. In the superoxide dismutase 1 
gene (SOD1; MIM*147450), a heterozygous 7bp deletion in intron 2 (IVS 2+50 del 7) was 
identified in two families with keratoconus
17
 but other groups have failed to detect SOD1
mutations in their patient cohorts
16, 18
. Genome wide association studies (GWAS) have been
conducted in keratoconus cohorts and identified SNPs in the hepatocyte growth factor (HGF; 
MIM*142409)
19
, RAB3 GTPase activating subunit 1 (RAB3GAP1; MIM*602536)
20
, and
lysyl oxidase (LOX; MIM*153455)
21
 associated with keratoconus susceptibility.
We recently identified a mutation miR-184(+57C>T) in the seed region of miR-184 (encoded 
by MIR184 [MIM*613146]) responsible for familial severe keratoconus combined with 
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early-onset anterior polar cataract by targeted resequencing of a 5.5 Mb linkage region at 
15q22-q24 known to contain the mutation
22
. A second identical mutation in MIR184 has been 
recently reported in a family with endothelial dystrophy, iris hypoplasia, congenital cataract, 
and stromal thinning (EDICT) syndrome (MIM#614303)
23, 24
. Axial myopia is associated 
with keratoconus and keratoconic eyes have on average longer axial and posterior segment 
lengths than emmetropic eyes
25
. In order to investigate the phenotypic spectrum resulting 
from MIR184 mutation and potential genotype-phenotype relationships, we sequenced 
MIR184 in a keratoconus cohort of mixed ethnicity and a Chinese cohort with axial myopia. 
A known SNP, rs41280052, located within the pre-miR-184 sequence was investigated to 
identify a possible association with keratoconus. 
Methods 
Patients 
Clinically affected keratoconus patients were recruited as part of ongoing studies from 
Belfast (Belfast Health and Social Care Trust, UK), Leeds (St. James’s University Hospital, 
Leeds, UK), Manchester (Central Manchester Foundation Trust, UK), Australia (Flinders 
University, Adelaide, Australia) and India (Aravind Eye Hospital, Madurai, India). The 
diagnosis of keratoconus was performed by an experienced ophthalmologist based on well-
established clinical signs on slit-lamp biomicroscopy, cycloplegic retinoscopy and corneal 
topography. Patients with at least one clinical sign of the disease in conjunction with a 
confirmatory corneal topography map were considered as having keratoconus. 
A cohort from a Han Chinese population with axial myopia was recruited as part of ongoing 
myopia genetics studies
26-28
 at The Hong Kong Polytechnic University. Myopic subjects were 
excluded if they showed obvious signs of ocular disease or other inherited disease associated 
with myopia. 
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All studies adhered to the tenets of Declaration of Helsinki, and were approved by the 
relevant institutional review boards, with all participants giving written informed consent. 
PCR Amplification and DNA Sequencing 
Genomic DNA was extracted from peripheral blood leukocytes from all subjects using 
commercial kits according to the manufacturer’s instructions. PCR primers for amplification 
of the MIR184 stem loop sequence (as presented in miRBase; MI0000481) and flanking 
regions were designed using Primer3 Detective V1.01 program 
(http://frodo.wi.mit.edu/primer3/)
29
: miR-184F 5′-CCAGGTGTCAGAGGGAGAGA-3′ and 
miR-184R 5′-CCAAGGTCTCCTCCTGGAAT-3′. Sanger sequencing of MIR184 was 
performed (conditions available on request) and the sequencing results were analysed 
manually using the sequence analysis software SeqScape version 2.1.1 (Applied Biosystems, 
Foster City, CA, USA). Mutations were annotated in accordance with the sequence presented 
in miRBase (MI0000481). Secondary structural effects of identified mutations were assessed 
computationally using mFold (http://mfold.rna.albany.edu/?q=mfold)
30
 and RNAFold 
algorithms (http://www.tbi.univie.ac.at/RNA/index.html). The conservation of the 
nucleotides across species was analysed using the UCSC genome browser 
(http://genome.ucsc.edu/). 
Ex vivo miR-184 expression analysis 
MIR184 amplicons from patients harbouring mutations were gel purified using a GeneJET 
Gel Extraction Kit (Fermentas, UK) following manufacturer’s instructions and cloned into 
Vivid Colors pcDNA 6.2/N-EmGFP-GW/TOPO Mammalian Expression Vector (Life 
Technologies, Paisley, UK) following the manufacturer’s protocol. The resulting recombinant 
plasmids containing inserts with mutations in MIR184 and WT controls were transfected into 
Human Embryonic Kidney 293T (HEK293T) cells from the American Type Culture 
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Collection (ATCC). The cells were cultured in DMEM (Life Technologies, Paisley, UK) 
supplemented with 10 % fetal calf serum and 100 μg/ml PrimocinTM (InvivoGen, USA). 
Transfections were performed using TurboFect Transfection Reagent (Fermentas, UK) 
according to the manufacturer’s protocol. At least three independent biological replicates 
were performed for each transfection (untransfected control: n = 3; WT: n = 3; miR-
184(+3G>A): n = 6; miR-184(+8C>A): n = 3).  RNA was extracted from the cells 20 hours 
after transfection using miRNeasy Mini Kit (Qiagen, UK) according to the manufacturer’s 
instructions. 
Quantitative Real Time PCR (RT-qPCR) 
RT-qPCR was performed using TaqMan MicroRNA assays [hsa-miR-184 (000485), hsa-
miR-103 (000439), hsa-miR-218 (000521); Life Technologies, Paisley, UK] according to 
manufacturer’s instructions with 5 ng of total RNA. For each biological replicate, three PCR 
technical replicates were performed. Reactions were amplified  using the LightCycler 480 
Real-Time PCR System (Roche, UK) (conditions available on request).  Cycle threshold (Ct) 
values were calculated using LightCycler 480 software 1.5 (Roche, UK) and then differences 
in expression were analysed with the relative expression software tool (REST)
31
. Differences 
in expression were considered statistically significant at P < 0.05. 
rs41280052 SNP genotyping assay 
The genotype of SNP rs41280052 in 692 Caucasian keratoconus cases was determined 
through the sequencing of the MIR184 gene. Unaffected individuals (n=1865) were obtained 
from the Blue Mountains Eye Study. All were Caucasian aged over 49 years of age and had 
an ophthalmological examination; the recruitment of this cohort has been described 
previously
32
. Unaffected controls were genotyped using a custom designed Taqman SNP 
genotyping assay and Taqman SNP Genotyping Master Mix  performed according to 
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manufacturer’s protocols on a StepOnePlus Real Time PCR instrument (Life Technologies; 
Mulgrave, Victoria, Australia) (https://www5.appliedbiosystems.com/tools/genotyping/). 
Association of the SNP with keratoconus was assessed by Chi-square test. 
Results 
MiR-184 sequencing 
A total of 780 unrelated keratoconus patients were recruited; 667 of European Caucasian and 
123 of South Indian origin. In addition, 96 patients with axial myopia (mean spherical error -
9.75 dioptres; mean cylindrical error -1.31 dioptres, mean spherical equivalent -10.41 
dioptres and mean axial length 27.60mm) and 96 controls (spherical equivalent within +/- 1.0 
dioptres) were recruited in Hong Kong and were all unrelated Han Chinese. No sequence 
variants were identified in MIR184 in the myopia subjects. Two novel heterozygous 
substitution mutations in MIR184 were identified in two patients from the keratoconus 
cohort: miR-184(+3A>G) and miR-184(+8C>A) (Fig. 1). Both patients were Caucasian, one 
from Australia [miR-184(+3A>G)] and one from the UK [miR-184(+8C>A)]. Both variants 
were absent from ethnically matched controls without ocular disease (96 UK and 96 
Australian controls) and the 1000 Genomes Project data, release 12 – May 2012 
(http://browser.1000genomes.org/index.html; accessed July 2012). The mutation miR-
184(+8C>A) was identified in the NHLBI GO Exome Sequencing Project dataset (Exome 
Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA 
(http://evs.gs.washington.edu/EVS/; accessed July 2012) with a minor allele frequency of 
0.01% while miR-184(+3A>G) was not present in the ESP data. The cytosine at position 8 of 
pre-miR-184 is highly conserved across all species and the adenine at position 3 is well 
conserved although a guanine is present in some rodents (Figure 2). 
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Clinical details 
The UK patient [miR-184(+8C>A)] was a 43-year-old male with a Snellen best corrected 
visual acuity of 20/32 (right eye) and 20/20 (left eye) with contact lenses. On slit-lamp 
biomicroscopy there was definite keratoconus and Orbscan II (Bausch & Lomb, Salt Lake 
City, UT, USA) topography confirmed keratoconus (Fig. 1). The central corneal thickness 
was 458μm (right eye) and 449μm (left eye). Keratometry measurements were 52.3/49.1 
diopter (D) (right eye) and 49.3/46.7D in the left eye. There was no evidence of anterior 
segment dysgenesis, no iris or lenticular abnormalities, and the fundi were normal. The 
female sibling of the proband had a normal ocular examination including corneal topography 
and had a wild-type miR-184 sequence. DNA was available from one elderly infirm parent 
who carried the same mutation (+8C>A) but was unable to undergo a clinical examination 
(Fig.3). Historically there was no mention of a diagnosis of keratoconus in this parent but 
keratoconus or forme fruste could not be excluded. 
The Australian patient [miR-184(+3A>G)] was a 55-year-old male with bilateral keratoconus 
with a Snellen best corrected visual acuity of 20/20 (right eye) and 20/32 (left eye) with 
contact lenses. On slit-lamp biomicroscopy there was definite keratoconus with anterior 
stromal scarring on the apex of the cone, prominent corneal nerves and unique cortical 
granular cataract. There were no iris abnormalities or anterior segment dysgenesis, and the 
fundi were normal. Pentacam (Oculus, Wetzlar, Germany) topography confirmed 
keratoconus (Fig. 1). The central corneal thickness was 497 μm (right eye) and 385 μm (left 
eye). Keratometry measurements were 41.7/41D (right eye) and 58/50.5D in the left eye. The 
patient had an affected brother who carries the same mutation. This patient had bilateral 
keratoconus with a Snellen best corrected visual acuity of 20/32 (right eye) and 20/20 (left 
eye) with contact lenses. On slit-lamp biomicroscopy there was definite keratoconus and very 
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subtle cortical granular cataracts. There were no iris abnormalities or anterior segment 
dysgenesis, and the fundi were normal. Pentacam (Oculus, Wetzlar, Germany) topography 
confirmed keratoconus. The central corneal thickness was 378 μm (right eye) and 408 μm 
(left eye). Keratometry measurements were 48.2/46.5D (right eye) and 45.0/44.6D in the left 
eye. 
Examination of the parents in the Australian family (Fig.3) revealed that neither parent has 
keratoconus (K readings: mother: right eye 42.75/42.75D, left eye 43.0/42.75D; Father: right 
eye 43.0/41.87D, left eye 42.75/42.37D). Both parents have thin central corneas (Mother: 
right eye 480 µm, left eye 473 µm; Father: right eye 509 µm, left eye 521 µm). The mother 
displayed prominent corneal nerves and a similar granular cortical cataract as observed in the 
brothers. The father has central corneal haze and a Hudson-Stahli iron line. Sequencing of the 
MIR184 gene in the parents revealed that the father carries the same mutation (+3A>G). 
Therefore, the cataract observed in the mother and her two sons is not related to this 
mutation. As neither parent displays keratoconus, this mutation appears to be associated with 
reduced penetrance in the father, or alternatively is not the causative mutation in this family. 
MiR-184 modelling 
In order to model the effects of these mutations on the miR-184 stem loop stability and 
secondary structure, we used the mFold
30
 and RNAFold algorithms. The minimum free 
energy prediction (ΔG) for WT miR-184 was ΔG = -35.50 kcal/mol compared to miR-
184(+3A>G) with ΔG = -34.70 kcal/mol and miR-184(+8C>A) with ΔG = -33.40 kcal/mol 
(Figure 2). Both mFold and RNAFold algorithms predicted reduced stability for miR-
184(+3A>G) and miR-184(+8C>A) indicated by a change in Gibbs free energy (ΔG) of +0.8 
kcal/mol and +2.1 kcal/mol respectively. While the Gibbs free energy predictions of the 
mutant miR-184 sequences lie within the normal range (e.g. Gibbs free energy prediction of 
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miR-100 = -25.7 and of miR-183 = -40.50), this predicted reduced stability of miR-184 could 
affect the processing of the miRNA. Both mutations, miR-184(+3A>G) and miR-
184(+8C>A) alter the stem loop secondary structure of miR-184. The mutation at position 3 
changes an adenine residue which normally binds to a uracil in the wild type miR-184 stem 
loop structure, to a guanine residue, resulting in a reduced base pair probability. For the 
mutation at position 8, substitution of a cytosine residue which normally binds guanine in the 
wild type miR-184 stem loop structure, to adenine residue increases a bulge of non-paired 
residues from six to eight (demonstrated in Figure 2). 
Ex vivo miR-184 expression analysis 
Expression levels of mature miR-184 were analysed by stem-loop RT-qPCR  relative to miR-
103 (data not shown) and miR-218 expression levels (Figure 2). Both reference microRNAs 
showed constant expression in all samples and delivered comparable results. As expected, 
untransfected HEK293T did not express miR-184 and a statistically significant increase in 
miR-184 expression was observed after transfection with WT miR-184 (P < 0.001). 
Transfection of miR-184(+3A>G) and miR-184(+8C>A) showed statistically significant 
reduction of miR-184 levels compared to transfected WT miR-184 (P = 0.002 and P = 0.022  
respectively). While miR-184(+8C>A) almost completely repressed the expression of miR-
184, miR-184(+3A>G) reduced the expression of miR-184 by approximately 40%. 
SNP Association 
A total of 692 keratoconus patients (1384 chromosomes) and 1865 control individuals (3730 
chromosomes) were genotyped for SNP rs41280052 which lies within the stem loop of miR-
184. In the keratoconus group, 1366 chromosomes carried the major allele (G) and 18 carried 
the minor allele (T) resulting in a minor allele frequency of 1.3%. For the control group, 3668 
chromosomes carried the major allele and 62 chromosomes carried the minor allele resulting 
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in a minor allele frequency of 1.7%. A Pearson’s chi-squared test gave a chi-squared value 
(χ2) of 0.86, 1 degree of freedom (d.f.), p-value = 0.3537. Hence, no significant association 
with keratoconus was observed for rs41280052. The minor allele frequencies for rs41280052 
reported on dbSNP (Build 137) were 0.6% (1000 Genomes Project data) and 2.1% (ClinSeq 
project)
33
. 
Discussion 
MicroRNAs (miRNA) are small (19-25 nucleotides), single-stranded non-coding RNAs 
which are important regulators of eukaryotic gene expression in most biological processes
34-
36
. They act by guiding the RNA-induced silencing complex (RISC) to partially 
complementary sequences in target mRNAs, mainly in the 3′-untranslated region (3'UTR), to 
suppress gene expression by a combination of translational inhibition and mRNA decay. The 
seed sequence consists of 2-8 nucleotides in the 5′ end of the mature miRNAs and form the 
most important residues in determining mRNA target sites. Transcription of miRNAs in the 
nucleus results in long transcripts known as primary miRNA transcripts (pri-miRNA) which 
are processed and cleaved by Drosha into smaller approximately 70 nt stem-loop miRNA 
precursors (pre-miRNA). Pre-miRNAs are exported into the cytoplasm by Exportin-5 where 
they are further cleaved by Dicer to produce the 19-25 nt long miRNA duplex. Only one 
strand, the mature miRNA, is incorporated into the miRNA-induced silencing complex 
(miRISC) while the other strand, known as miRNA-star (miRNA*), is degraded. Within the 
miRISC complex, miRNAs then bind to their target mRNAs to regulate gene expression
34-36
. 
The structures of miRNA precursors are crucial for recognition and cleavage by Drosha and 
Dicer proteins during miRNA processing
37
. Structural changes induced by mutations are 
likely to interfere with the processing of miRNAs, altering miRNA expression or modifying 
downstream processes and pathways. 
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The first example of point mutations in a miRNA involved in human disease was reported by 
Mencia et al. (2009) who identified two mutations in the seed region of MIR96 in two 
Spanish families affected by nonsyndromic progressive hearing loss
38
. We recently reported a 
mutation [miR-184(+57C>T)] in the seed region of MIR184 in a family with severe 
keratoconus and anterior polar cataract. Subsequently, a second identical mutation in MIR184 
was reported in a family with EDICT syndrome
23, 24
. At this time we are unable to confirm 
whether the MIR184 mutation arose independently or whether the families are distantly 
related. The corneal phenotype in EDICT syndrome was described as non-ectatic thinning 
with a uniform corneal steepening on corneal topography
39, 40
. That is, the corneal phenotype 
was not typical of keratoconus clinically or histologically
39, 40
. The Northern Irish family in 
whom we identified the MIR184 mutation [miR-184(+57C>T)]
22
 had clinical and 
topographic features of severe keratoconus
39
. In order to determine the role of MIR184 
mutations in the development of keratoconus, we sequenced MIR184 in a large keratoconus 
cohort of mixed ethnicity from the UK, India and Australia. Our data expands the current 
phenotypic spectrum for MIR184 mutations which ranges from keratoconus to keratoconus 
associated with cataract
22, 41
 to complete anterior segment dysgenesis
23, 24, 40
. Screening of 
MIR184 in a cohort of 96 myopia patients from Hong Kong did not reveal any mutations, 
indicating that in this patient population MIR184 does not play a major role in myopia 
pathogenesis. 
We detected two novel heterozygous mutations in MIR184 in a two keratoconus patients, 
both of Caucasian origin: miR-184(+3A>G) and (+8C>A). These patients had definitive 
evidence of keratoconus on slit lamp examination and corneal topography, indicating the role 
of MIR184 mutation in the pathogenesis of isolated keratoconus. Given that the penetrance of 
the miR-184(+3A>G) mutation is not complete and we were unable to verify segregation of 
the miR-184(+8C>A) mutation, computational modelling and functional assays were 
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employed to confirm the pathogenicity of the identified mutations. Computational analysis of 
the identified mutations in MIR184 predicted structural changes altering the stem loop 
secondary structure of pri-miR-184, as indicated by changes in Gibbs free energy of mutant 
forms of miR-184 compared to wild type miR-184. The structure of the precursor miRNA is 
crucial for Drosha cleavage, Exportin-5 recognition as well as for Dicer recognition and 
cleavage specificity. The identified mutations, modifying the stem-loop precursor structure of 
miR-184, could interfere with both the efficiency of processing and the site of cleavage by 
Drosha. Changes in the cleavage site would alter the ends of the miR-184 pre-miR and 
therefore potentially affect Exportin-5 recognition or Dicer processing, resulting in altered 
expression levels of the mature microRNA. A modification in the Dicer cleavage position 
would produce a different mature miRNA sequence
37
 with an altered seed region. 
Cloning and transfection of mutant MIR184 transcripts into HEK293T cells resulted in a 
decrease in mature miR-184 expression levels compared to transfected miR-184 WT 
transcripts indicating altered miRNA processing. The miR-184(+8C>A) mutation identified 
in the UK patient was predicted to increase the size of an internal loop close to the hairpin 
base and resulted in a complete loss of mir184 expression. The miR-184(+3A>G) mutation 
was predicted to reduce the base pair probability at position 3 of the miRNA stem loop 
structure in the junction region between single-stranded RNA and double-stranded RNA. 
This region is essential for recognition and cleavage by Drosha 
37
, and may be disrupted by 
the mutation at position 3 of the miR-184 stem loop structure resulting in the observed 
decreased expression level of miR-184. The impact of the miR-184(+3A>G) mutation on the 
level of miR-184 expression was less than that observed for the miR-184(+8C>A) (Figure 2), 
consistent with the incomplete penetrance of this mutation in the Australian family. The 
penetrance of the miR-184(+3A>G) mutation is not complete, given that the carrier parent 
did not manifest keratoconus under the commonly used definitions, nor was forme fruste 
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keratoconus evident. However, both parents have some subtle features that are often part of 
the keratoconus description (thin corneas, corneal haze, prominent corneal nerves). Thus, we 
hypothesise that the mother, while not harbouring a MIR184 mutation, likely carries other 
undefined keratoconus genetic risk factors, which have been inherited by her offspring. These 
factors, in conjunction with the MIR184 mutation, have led to overt keratoconus in the 
proband and his brother. This polygenic threshold model of disease has long been proposed 
in complex disease and has been explored extensively in relation to disorders such as 
schizophrenia
42
. 
Approximately 60% of human protein coding genes are estimated to be regulated by 
miRNAs
35
. One miRNA can target hundreds of downstream target mRNAs, while one 
mRNA can be targeted by multiple miRNAs
35
. Mutations in the mature miR-184 sequence 
would alter mRNA target specificity leading to a cascade of downstream effects on gene 
expression. Mutations which reduce the expression of mature miR-184 would reduce the 
regulatory effect upon its target genes. Messenger RNAs targeted by miRNAs can be 
predicted in silico using a range of algorithms
43
 but require functional characterisation. In 
epithelia, miR-184 competitively inhibits the binding of miR-205, encoded by MIR205 
(MIM*613147), to mRNA of the inositol polyphosphate phosphatase-like 1 gene (INPPL1 
MIM*600829). Functionally, we demonstrated that the miR-184 mutant fails to compete with 
miR-205 for overlapping target sites on the 3'UTRs of INPPL1 and ITGB4 
22
. There is 
biological evidence that both INPPL1 and ITGB4 are involved in the pathogenesis of 
keratoconus
22
. Recently, miR-184 was shown to regulate the differentiation of human-
induced pluripotent stem cells into corneal epithelial-like cells. Knockdown of miR-184 
caused a decrease in paired box gene 6 (PAX6; MIM*607108), a major regulator of eye 
development, and keratin 3 (K3; MIM*148043), expression during differentiation
44
. 
Identification of miR-184 target genes and regulatory pathways may explain the phenotypic 
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spectrum observed in patients harbouring miR-184 mutations but more importantly will assist 
in the identification of new keratoconus susceptibility genes. 
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Figure Legends 
Figure 1: Sequence chromatograms showing the novel heterozygous substitution mutation 
miR-184(+3A>G) detected in a keratoconus patient from the Australian cohort (A.) and miR-
184(+8C>A) detected in a keratoconus patient from the UK cohort (B.); Corneal topography 
maps confirming typical keratoconus pattern with anterior corneal steepening (top) and 
corneal thinning (bottom) in the right (OD) and left (OS) eye of the Australian patient 
carrying miR-184(+3A>G) using Pentacam (Oculus, Wetzlar, Germany) (C.) and of the UK 
patient carrying miR-184(+8C>A) using Orbscan II (Bausch & Lomb, Salt Lake City, UT, 
USA) (D.) 
Figure 2: A. Adenine at position 3 of miR-184 is well conserved across mammals and 
cytosine at position 8 is well conserved of across all species; B. The identified mutations 
were predicted to cause structural changes of the stem loop precursor of miR-184. Colours 
represent positional entropy. Left to right: miR-184 WT, 3A>G and 8C>A; C. Relative 
expression levels of miR-184 were significantly decreased after transfection with mutant 
transcripts compared to transfection with WT miR-184 transcripts. (Average relative 
expression of biological replicates and standard deviations are shown; untransfected control: 
n = 3; WT: n = 3; miR-184(+3A>G): n = 6; miR-184(+8C>A): n = 3). * P < 0.05, ** P <0.01, 
*** P < 0.001. 
 
Figure 3: Pedigree diagrams of the Australian family (left) and UK family (right). The 
proband of each family is indicated by an arrow. 
 
 
 
